Zoungas Sophia, Cameron James D, Kerr Peter G, Wolfe Rory, Muske Christine, McNeil John J, McGrath Barry P
Centre for Vascular Health, Monash University, Dandenong Hospital, Dandenong, Victoria, Australia.
Am J Kidney Dis. 2007 Oct;50(4):622-30. doi: 10.1053/j.ajkd.2007.07.012.
Indices of arterial structure and stiffness are proposed as surrogate markers of cardiovascular disease in patients with chronic kidney disease (CKD), but no study examined multiple markers in the same population.
Prospective observational study.
SETTING & PARTICIPANTS: 315 subjects with stages 4 to 5 CKD, aged 24 to 79 years (mean age, 56.6 +/- 13.6 [SD] years), enrolled in the Atherosclerosis and Folic Acid Supplementation Trial.
Carotid arterial intima-medial thickness (IMT; n = 315) and indices of arterial stiffness (n = 207), including aortofemoral pulse wave velocity (PWV[a-f]), systemic arterial compliance (SAC), and carotid-derived augmentation index.
The primary outcome was a composite of all fatal and nonfatal cardiovascular events.
During follow-up (median, 3.6 years), 95 cardiovascular events occurred. On Cox proportional-hazard modeling, mean maximum IMT, PWV(a-f), and SAC were predictive of the composite clinical end point of all cardiovascular events, but carotid-derived augmentation index was not (hazard ratio [HR] for every 0.01-mm increase in IMT, 1.09; P = 0.001; 95% confidence interval [CI], 1.03 to 1.14; HR for every 1-m/s increase in PWV(a-f), 1.18; P < 0.001; 95% CI, 1.12 to 1.25; HR for every 0.01-U/mm Hg decrease in SAC, 0.98; P = 0.01; 95% CI, 0.97 to 0.99). After adjustment for age, sex, blood pressure, diabetes, past cardiovascular disease, cholesterol level, and smoking, PWV(a-f) remained a significant independent predictor of cardiovascular events (adjusted HR, 1.12; P = 0.001; 95% CI, 1.05 to 1.20), but IMT and SAC did not.
Study power to analyze differences between predialysis and dialysis stages of CKD.
PWV(a-f) is the only arterial index independently associated with cardiovascular outcome in patients with CKD.
动脉结构和僵硬度指标被提议作为慢性肾脏病(CKD)患者心血管疾病的替代标志物,但尚无研究在同一人群中检测多种标志物。
前瞻性观察性研究。
315例4至5期CKD患者,年龄24至79岁(平均年龄56.6±13.6[标准差]岁),纳入动脉粥样硬化与叶酸补充试验。
颈动脉内膜中层厚度(IMT;n = 315)和动脉僵硬度指标(n = 207),包括主动脉股动脉脉搏波速度(PWV[a-f])、全身动脉顺应性(SAC)和颈动脉衍生的增强指数。
主要结局是所有致命和非致命心血管事件的复合结局。
在随访期间(中位数为3.6年),发生了95例心血管事件。在Cox比例风险模型中,平均最大IMT、PWV(a-f)和SAC可预测所有心血管事件的复合临床终点,但颈动脉衍生的增强指数不能(IMT每增加0.01 mm的风险比[HR]为1.09;P = 0.001;95%置信区间[CI]为1.03至1.14;PWV(a-f)每增加1 m/s的HR为1.18;P < 0.001;95%CI为1.12至1.25;SAC每降低0.01 U/mm Hg的HR为0.98;P = 0.01;95%CI为0.97至0.99)。在调整年龄、性别、血压、糖尿病、既往心血管疾病、胆固醇水平和吸烟因素后,PWV(a-f)仍然是心血管事件的显著独立预测指标(调整后HR为1.12;P = 0.001;95%CI为1.05至1.20),但IMT和SAC不是。
研究效能不足以分析CKD透析前和透析阶段之间的差异。
PWV(a-f)是CKD患者中唯一与心血管结局独立相关的动脉指标。